Physician profile
Brindusa Truta
NPI 1558469643
$1,591.45
in general payments reported to CMS, 2019-2025
8 companies · $91.90 in 2025
The $91.90 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $52.96 · 2021: $156 · 2022: $600 · 2023: $541 · 2024: $22.15 · 2025: $91.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $504.58 | 2020-2024 | Stelara |
| Abbvie INC. | $470.04 | 2019-2023 | Rinvoq, Creon, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $288.73 | 2019-2025 | Entyvio |
| Pfizer INC. | $223.14 | 2021-2023 | |
| Lilly USA, LLC | $50.33 | 2025 | Omvoh |
| Organon LLC | $22.40 | 2022 | |
| Merck Sharp & Dohme LLC | $17.98 | 2023 | Dificid |
| Celgene Corporation | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brindusa Truta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.